Filter by
Blood, tissues, cells and organs - Key documents (159)
RSS2024 RAB and RATC annual summary of activity
Summary of the 2023 (2022 data) annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2023 (2022 data) annual reporting of serious adverse reactions and events for tissues and cells
2023 VES annual report - Vigilance Expert Subgroup (VES) of the National Competent Authorities (NCA) for Substances of Human Origin Expert Group
2023 RAB and RATC annual summary of activity
Summary of the 2022 (2021 data) annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2022 (2021 data) annual reporting of serious adverse reactions and events for tissues and cells
Tissues and cells - Common approach for definition of reportable Serious Adverse Events and Reactions (SARE)
Blood - Common approach for definition of reportable Serious Adverse Events and Reactions (SARE)
Summary of the 2021 (2020 data) annual reporting of serious adverse reactions and events for tissues and cells
Summary of the 2021 (2020 data) annual reporting of serious adverse reactions and events for tissues and cells
2022 VES annual report - Vigilance Expert Subgroup (VES) of the National Competent Authorities (NCA) for Substances of Human Origin Expert Group
2022 RAB and RATC annual summary of activity
Report on the implementation of Directive 2010/53/EU on standards of quality and safety of human organs intended for transplantation
COM(2022) 338 final
2021 RAB and RATC annual summary of activity
2021 VES annual report - Vigilance Expert Subgroup (VES) of the National Competent Authorities (NCA) for Substances of Human Origin Expert Group
Summary of the 2020 annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2020 annual reporting of serious adverse reactions and events for tissues and cells